Tofacitinib as a Promising Therapeutic Option in Refractory Autoimmune-Mediated Vascular and Sclera Inflammation
Mediterr J Rheumatol
.
2023 Sep 29;34(3):282-283.
doi: 10.31138/mjr.20230929.taa.
eCollection 2023 Sep.
Author
Theodoros Dimitroulas
1
Affiliation
1
4 Department of Internal Medicine, Hippokration Hospital, School of Medicine, Aristotle University Thessaloniki, Greece.
PMID:
37941867
PMCID:
PMC10628872
DOI:
10.31138/mjr.20230929.taa
No abstract available
Keywords:
JAK inhibitors; Takayasu; autoimmune scleritis; tofacitinib.
Publication types
Editorial